While no overall significant differences were observed between any of the aforementioned clinical factors (despite CDK4 expression seen in all patients), a larger population size (greater than 173), which also evaluated the risk in other subtypes of PC, including PanNETs, would establish a more thorough understanding into the expression of CDK4 in PC patients. Here, CDK4 is linked to pachyonychia congenita.